肾素-血管紧张素系统与代谢综合征
The renin angiotensin system and the metabolic syndrome.
作者信息
Wang Chih-Hong, Li Feng, Takahashi Nobuyuki
机构信息
Department of Pathology and Laboratory Medicine The University of North Carolina at Chapel Hill Chapel Hill, NC 27599-7525.
出版信息
Open Hypertens J. 2010;3:1-13. doi: 10.2174/1876526203010001.
Abstract
The renin angiotensin system (RAS) is important for fluid and blood pressure regulation. Recent studies suggest that an overactive RAS is involved in the metabolic syndrome. This article discusses recent advances on how genetic alteration of the RAS affects cardiovascular and metabolic phenotypes, with a special emphasis on the potential role of angiotensin-independent effects of renin.
摘要
肾素血管紧张素系统（RAS）对体液和血压调节至关重要。最近的研究表明，过度活跃的RAS与代谢综合征有关。本文讨论了RAS基因改变如何影响心血管和代谢表型的最新进展，特别强调了肾素非血管紧张素依赖性效应的潜在作用。
相似文献
1
The renin angiotensin system and the metabolic syndrome.肾素-血管紧张素系统与代谢综合征
Open Hypertens J. 2010;3:1-13. doi: 10.2174/1876526203010001.
2
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.关于肾内肾素-血管紧张素系统的新见解和新视角：关注内泌/细胞内血管紧张素 II。
Peptides. 2011 Jul;32(7):1551-65. doi: 10.1016/j.peptides.2011.05.012. Epub 2011 Jun 14.
3
[Network regulation of renin-angiotensin system on the cardiovascular diseases].肾素-血管紧张素系统对心血管疾病的网络调节
Sheng Li Ke Xue Jin Zhan. 2013 Jun;44(3):183-7.
4
Intratubular and intracellular renin-angiotensin system in the kidney: a unifying perspective in blood pressure control.肾脏内管腔内和细胞内的肾素-血管紧张素系统：血压控制的统一观点。
Clin Sci (Lond). 2018 Jul 9;132(13):1383-1401. doi: 10.1042/CS20180121. Print 2018 Jul 16.
5
The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.心血管自主控制中的肾素-血管紧张素系统：最新进展及其临床意义。
Clin Auton Res. 2019 Apr;29(2):231-243. doi: 10.1007/s10286-018-0572-5. Epub 2018 Nov 9.
6
Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue.肾素-血管紧张素系统在白色和棕色脂肪组织中的调节和功能。
Compr Physiol. 2017 Sep 12;7(4):1137-1150. doi: 10.1002/cphy.c160031.
7
Megalin-Mediated Endocytosis in the Kidney Proximal Tubule: Relevance to Regulation of the Renal Renin-Angiotensin System.巨蛋白介导的肾近端小管内吞作用：与肾素-血管紧张素系统调节的相关性
Nephron. 2023;147(3-4):244-249. doi: 10.1159/000526369. Epub 2022 Sep 12.
8
Recent Advances in Understanding the Molecular Pathophysiology of Angiotensin II Receptors: Lessons From Cell-Selective Receptor Deletion in Mice.理解血管紧张素II受体分子病理生理学的最新进展：来自小鼠细胞选择性受体缺失的经验教训。
Can J Cardiol. 2023 Dec;39(12):1795-1807. doi: 10.1016/j.cjca.2023.06.421. Epub 2023 Jul 1.
9
Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.肾小球肾素-血管紧张素系统（RAS）的激活参与了肾小球损伤的发生和进展。
Clin Exp Nephrol. 2012 Apr;16(2):214-20. doi: 10.1007/s10157-011-0568-0. Epub 2011 Dec 2.
10
The renin angiotensin system and the metabolic syndrome.肾素-血管紧张素系统与代谢综合征。
Physiol Behav. 2010 Jul 14;100(5):525-34. doi: 10.1016/j.physbeh.2010.03.018. Epub 2010 Apr 8.
引用本文的文献
1
Glucose Increases Hepatic Mitochondrial Antioxidant Enzyme Activities in Insulin Resistant Rats Following Chronic Angiotensin Receptor Blockade.葡萄糖可增加慢性血管紧张素受体阻断后胰岛素抵抗大鼠肝脏线粒体抗氧化酶的活性。
Int J Mol Sci. 2022 Sep 17;23(18):10897. doi: 10.3390/ijms231810897.
2
The gene knockout of angiotensin II type 1a receptor improves high-fat diet-induced obesity in rat via promoting adipose lipolysis.血管紧张素 II 型 1a 受体基因敲除通过促进脂肪脂解改善高脂肪饮食诱导的肥胖大鼠模型的肥胖。
PLoS One. 2022 Jul 8;17(7):e0267331. doi: 10.1371/journal.pone.0267331. eCollection 2022.
3
Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.肝脏代谢中的肾素-血管紧张素系统：性别差异与肠促胰岛素的作用。
Metabolites. 2022 May 3;12(5):411. doi: 10.3390/metabo12050411.
4
The Crowded Uterine Horn Mouse Model for Examining Postnatal Metabolic Consequences of Intrauterine Growth Restriction vs. Macrosomia in Siblings.用于研究同胞中子宫内生长受限与巨大儿的产后代谢后果的拥挤子宫角小鼠模型。
Metabolites. 2022 Jan 22;12(2):102. doi: 10.3390/metabo12020102.
5
COVID's Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19.新冠病毒的奥卡姆剃刀原理：RAS失衡，新冠疫情不同寻常、出人意料方面的共同因素。
Diabetes Metab Syndr Obes. 2020 Sep 11;13:3169-3192. doi: 10.2147/DMSO.S265518. eCollection 2020.
6
Antimetabolic Syndrome Effect of Phytosome Containing the Combined Extracts of Mulberry and Ginger in an Animal Model of Metabolic Syndrome.含桑姜复合提取物的植物药对代谢综合征动物模型的抗代谢综合征作用。
Oxid Med Cell Longev. 2019 Nov 11;2019:5972575. doi: 10.1155/2019/5972575. eCollection 2019.
7
Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.阿齐沙坦、阿利吉仑及其联合用药对高脂饮食诱导的大鼠非酒精性肝病模型的影响。
Med Arch. 2017 Aug;71(4):251-255. doi: 10.5455/medarh.2017.71.251-255.
8
Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade.通过1型血管紧张素II受体阻断增强脂肪细胞棕色化
PLoS One. 2016 Dec 19;11(12):e0167704. doi: 10.1371/journal.pone.0167704. eCollection 2016.
9
The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.mAKAPβ在血管紧张素II诱导的心肌细胞肥大过程中的作用。
Int J Mol Med. 2015 May;35(5):1159-68. doi: 10.3892/ijmm.2015.2119. Epub 2015 Mar 2.
10
Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma.血管紧张素II 1型受体在人肝细胞癌中的表达及临床意义
Exp Ther Med. 2014 Feb;7(2):323-328. doi: 10.3892/etm.2013.1411. Epub 2013 Nov 15.
本文引用的文献
1
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.代谢综合征的协调：国际糖尿病联盟流行病学与预防特别工作组、美国国立心肺血液研究所、美国心脏协会、世界心脏联盟、国际动脉粥样硬化学会以及国际肥胖研究协会的联合中期声明
Circulation. 2009 Oct 20;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. Epub 2009 Oct 5.
2
Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes.在链脲佐菌素诱导的糖尿病仓鼠中，糜蛋白酶抑制可提供胰岛保护。
J Pharmacol Sci. 2009 Aug;110(4):459-65. doi: 10.1254/jphs.09115fp. Epub 2009 Aug 1.
3
eNOS, metabolic syndrome and cardiovascular disease.内皮型一氧化氮合酶、代谢综合征与心血管疾病
Trends Endocrinol Metab. 2009 Aug;20(6):295-302. doi: 10.1016/j.tem.2009.03.005. Epub 2009 Jul 31.
4
5
Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.血管紧张素转换酶抑制可降低高脂饮食喂养的C57BL/6J小鼠的体重并改善其糖耐量。
Physiol Behav. 2009 Aug 4;98(1-2):192-7. doi: 10.1016/j.physbeh.2009.05.009. Epub 2009 May 22.
6
7
Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.低剂量血管紧张素转换酶抑制剂在饮食性肥胖大鼠中的代谢作用。
Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):49-55. doi: 10.1016/j.numecd.2009.02.004. Epub 2009 Apr 9.
8
The kallikrein-kinin system in health and in diseases of the kidney.健康与肾脏疾病中的激肽释放酶-激肽系统。
Kidney Int. 2009 May;75(10):1019-30. doi: 10.1038/ki.2008.647. Epub 2009 Feb 4.
9
Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity?人肾素基因转基因大鼠的能量代谢：肾素与肥胖有关吗？
Hypertension. 2009 Mar;53(3):516-23. doi: 10.1161/HYPERTENSIONAHA.108.124966. Epub 2009 Jan 26.
10
Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.阿利吉仑：一种用于治疗高血压的口服直接肾素抑制剂。
Pharmacotherapy. 2009 Feb;29(2):193-212. doi: 10.1592/phco.29.2.193.
Zotero 插件